MicroRNA-185 targets SOCS3 to inhibit beta-cell dysfunction in diabetes

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Bao, Lidao ^a   Fu, Xudong ^b   Si, Mingwen ^b   Wang, Yi ^a   Ma, Ruilian ^a   Ren, Xianhua ^a   Lv, Haijun ^a  

^a AFFILIATED HOSPITAL OF INNER MONGOLIA MEDICAL UNIVERSITY   (China)

^b LIAOCHENG PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; MICRORNA; MICRORNA 185; SMALL INTERFERING RNA; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG; LUCIFERASE; MIRN185 MICRORNA, HUMAN; PRIMER DNA; SOCS3 PROTEIN, MOUSE; SUPPRESSOR OF CYTOKINE SIGNALING;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; COMPUTER MODEL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; DOWN REGULATION; DRUG EFFECT; EMBRYO; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANALYSIS OF VARIANCE; ANIMAL; CHINA; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; METABOLISM; SECRETION (PROCESS); WESTERN BLOTTING;

MUS;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CHINA; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INSULIN; INSULIN-SECRETING CELLS; LUCIFERASES; MICE; MICRORNAS; SUPPRESSOR OF CYTOKINE SIGNALING 3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84922738648     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116067     Document Type: Article

References (37)

1. Rochette L, Zeller M, Cottin Y, Vergely C (2014) Diabetes, oxidative stress and therapeutic strategies. Biochim Biophys Acta pii: S0304-4165(14): 00215-3.
2. Holman RR, Sourij H, Califf RM (2014) Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2diabetes. Lancet 383(9933):2008-2017. doi: 10.1016/S0140-6736(14)60794-7 PMID: 24910232
3. Seshasai SR, Kaptoge S, Thompson A, Thompson A, Di Angelantonio E, et al. (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364: 829-841. doi: 10.1056/ NEJMoa1008862 PMID: 21366474
4. Ley SH, Hamdy O, Mohan V, Hu FB (2014) Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet 383(9933): 1999-2007. doi: 10.1016/S0140-6736(14) 60613-9 PMID: 24910231
5. Ambros V (2004) The functions of animal microRNAs. Nature 431: 350-355. PMID: 15372042
6. FilipowiczW(2005) RNAi: The nuts and bolts of the RISC machine. Cell 122: 17-20. PMID: 16009129
7. Kato M, Castro NE, Natarajan R (2013) MicroRNAs: potential mediators and biomarkers of diabetic complications. Free Radic Biol Med 64: 85-94. doi: 10.1016/j.freeradbiomed.2013.06.009 PMID: 23770198
8. Staedel C, Darfeuille F (2013) MicroRNAs and bacterial infection. Cell Microbiol 15(9): 1496-1507. doi: 10.1111/cmi.12159 PMID: 23795564
9. Hwang HW, Mendel JT (2006) MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94: 776-780. PMID: 16495913
10. Shantikumar S, Caporali A, Emanueli C (2011) Role of microRNAa in diabetes and its cardiovascular complications. Cardiovasc Res 93(4): 583-593. doi: 10.1093/cvr/cvr300 PMID: 22065734
11. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, et al. (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432(7014): 226-30. PMID: 15538371
12. El Ouaamari A, Baroukh N, Martens GA, Lebrun P, Pipeleers D, et al. (2008) miR-375 targets 30-phosphoinositide- dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes 57: 2708-2717. doi: 10.2337/db07-1614 PMID: 18591395
13. Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F, et al. (2006) MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J Biol Chem 281: 26932-26942. PMID: 16831872
14. Lovis P, Gattesco S, Regazzi R (2008) Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biol Chem 389: 305-312. doi: 10.1515/BC.2008. 026 PMID: 18177263
15. Takahashi Y1, Forrest AR, Maeno E, Hashimoto T, Daub CO, et al. (2009) MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS One 4(8): e6677. doi: 10. 1371/journal.pone.0006677 PMID: 19688090
16. Yang M, Liu W, Pellicane C, Sahyoun C, Joseph BK, et al. (2014) Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake. J Lipid Res 55(2): 226-238. doi: 10.1194/jlr.M041335 PMID: 24296663
17. Standards of medical care in diabetes. (2010) Diabetes Care 33: S11-S61. doi: 10.2337/dc10-S011 PMID: 20042772
18. Xie J, Wei Q, Deng H, et al. (2014) Negative Regulation of Grb 10 Interacting GYF Protein 2 on Insulin- Like Growth Factor-1 Receptor Sinaling Pathway Caused Diabetic Mice Cognitive Impairments. PLoS One 9(9): e108559. doi: 10.1371/journal.pone.0108559 PMID: 25268761
19. Han X, Sun Y, Scott S, Bleich D (2001) Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and beta-cells. Diabetes 50(5): 1047-1055. PMID: 11334407
20. Babon JJ, Nicola NA (2012) The biology and mechanism of action of suppressor of cytokine signaling 3.Growth Factors 30(4): 207-219. doi: 10.3109/08977194.2012.687375 PMID: 22574771
21. Ilonen J, Akerblom HK (1999) New technologies and genetics of type 1 diabetes. Diabetes Technol Ther 1: 205-207. PMID: 11475295
22. Kahn SE (2001) Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 86(9): 4047-4058. PMID: 11549624
23. van de Bunt M, Gaulton KJ, Parts L, Moran I, Johnson PR, et al. (2013) The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis. PLoS One 8(1): e55272. doi: 10.1371/journal.pone.0055272 PMID: 23372846
24. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, et al. (2010) Plasma microRNA profiling reversal loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107(6): 810-817. doi: 10.1161/CIRCRESAHA.110.226357 PMID: 20651284
25. Meyer JM, Graf GA, van der Westhuyzen DR (2013) New developments in selective cholesteryl ester uptake. Curr Opin Lipidol 24(5): 386-392. doi: 10.1097/MOL.0b013e3283638042 PMID: 23842142
26. Imam J, Buddavarapu K, Lee-Chang J, Ganapathy S, Camosy C, et al. (2010) MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers. Oncogene 29: 4971-4979. doi: 10.1038/onc.2010.233 PMID: 20603620
27. Li Q, Wang JX, He YQ, Feng C, Zhang XJ (2014) MicroRNA-185 regulates chemotherapeutic sensitivity in gastric cancer by targeting apoptosis repressor with caspase recruitment domain. Cell Death Dis 5: e1197. doi: 10.1038/cddis.2014.148 PMID: 24763054
28. Liu M, Lang N, Chen X, Tang Q, Liu S, et al. (2011) miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells. Cancer Lett 301: 151-160. doi: 10.1016/j. canlet.2010.11.009 PMID: 21186079
29. Takahashi Y, Forrest AR, Maeno E, Hashimoto T, Daub CO, et al. (2009) MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS One 4: e6677. doi: 10.1371/ journal.pone.0006677 PMID: 19688090
30. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, et al. (1997) A family of cytokine-inducible inhibitors of signalling. Nature 387: 917-921. PMID: 9202125
31. Bjorbak C, Lavery HJ, Bates SH, Olson RK, Davis SM, et al. (2000) SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J Biol Chem 275: 40649-40657. PMID: 11018044
32. Rui L, Yuan M, Frantz D, Shoelson S, White MF (2002) SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem 277: 42394-42398. PMID: 12228220
33. Kloek C, Haq AK, Dunn SL, Lavery HJ, Banks AS, et al. (2002) Regulation of Jak kinases by intracellular leptin receptor sequences. J Biol Chem 277: 41547-41555. PMID: 12196522
34. Sands WA, Woolson HD, Milne GR, Rutherford C, Palmer TM (2006) Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells. Mol Cell Biol 26: 6333-6346. PMID: 16914720
35. Wang C, Dai J, Yang M, Deng G, Xu S, et al. (2014) Silencing of FGF-21 expression promotes hepatic gluconeogenesis and glycogenolysis by regulation of the Stat3-SOCS3 signal. FEBS J 281(9): 2136-2147. doi: 10.1111/febs.12767 PMID: 24593051
36. Wang J, Zhou H, Han Y, et al. (2014) SOCS3 methylation in synergy with Reg3A overexpression promotes cell growth in pancreatic cancer. J Mol Med (Berl) Jul 5 [Epub ahead of print].
37. Tomita S, Ishibashi K, Hashimoto K, Sugino T, Yanagida T, et al. (2011) Suppression of SOCS3 increases susceptibility of renal cell carcinoma to interferon-α. Cancer Sci 102(1): 57-63. doi: 10.1111/j. 1349-7006.2010.01751.x PMID: 21054677